1.04
price down icon1.89%   -0.02
after-market Handel nachbörslich: 1.09 0.05 +4.81%
loading

Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.55%
0.148
0.1416 0.109 0.075 0.0662
Operating Expenses
4.17%
17.57
18.33 12.14 14.25 14.96
Benefits Costs and Expenses
23.42%
11.84
15.46 11.36 12.48 13.42
Costs And Expenses
23.42%
11.84
15.46 11.36 12.48 13.42
Operating Income/Loss
4.24%
-17.42
-18.19 -12.03 -14.17 -14.89
Income/Loss From Continuing Operations Before Tax
-11.69
- -11.25 -12.41 -13.36
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
-11.69
- -11.25 -12.41 -13.36
Net Income/Loss
23.68%
-11.69
-15.32 -11.25 -12.41 -13.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
195.97K%
70.72
0.0361 70.62 70.53 70.49
Diluted Average Shares
195.97K%
70.72
0.0361 70.62 70.53 70.49
Basic Earnings Per Share
22.73%
-0.17
-0.22 -0.16 -0.18 -0.19
Diluted Earnings Per Share
22.73%
-0.17
-0.22 -0.16 -0.18 -0.19
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):